Effects of Maca Supplementation on Badminton-specific Exercise Performance

NCT ID: NCT07082985

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2024-01-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate whether a 14-day short-term supplementation of Maca can effectively mitigate oxidative stress and fatigue induced by badminton competition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Maca possesses antioxidant and anti-fatigue properties, which may have potential positive effects on athletic performance. This study integrates Maca's physiological characteristics with the sport-specific demands of badminton to examine its impact on athletic performance. The experiment is designed as a single-blind, crossover trial involving 12 participants, each undergoing two trials: a placebo trial and a Maca supplementation trial, with a supplementation period of 14 days for both conditions.

On the test day, participants will be provided with a meal adjusted according to their body weight and will orally consume either Maca or a placebo capsule. After a one-hour rest period, they will perform a simulated badminton match. At the end of each game, participants will complete a 30-second cycling anaerobic power test, followed by a 1-minute and 30-second rest before starting the next game.

Finally, participants will undergo an aerobic capacity assessment through a badminton-specific progressive endurance test, which will continue until exhaustion. Blood samples will be collected both before and after the simulated badminton match for analysis of oxidative stress markers, including malondialdehyde (MDA) and superoxide dismutase (SOD), as well as fatigue markers, such as blood urea nitrogen (BUN) and creatine kinase (CK). Additionally, the total duration of the badminton-specific progressive endurance test will be recorded.

Furthermore, to assess participants' psychological states, the Profile of Mood States (POMS) questionnaire will be administered after both the simulated badminton match and the badminton-specific progressive endurance test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Athletes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The study recruited twelve badminton athletes aged between 18 and 26 years, all of whom engage in regular physical training. Participants were crossed over for Maca or placebo supplements, which could be ended in two days.
Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Containing edible yellow No. 4, edible yellow No. 5, sucrose, silica, talc, oxidized starch, gelatin, magnesium stearate, and palm wax.

Group Type PLACEBO_COMPARATOR

Placebo (Placebo trial)

Intervention Type OTHER

The Placebo capsule supplement was taken for 14 days (4 capsules per day)

Maca (Maca trial)

Intervention Type OTHER

The Maca capsule supplement was taken for 14 days, with a daily dosage of 1600 mg of Maca (equivalent to 4 capsules per day, each containing 400 mg of Maca).

Maca

Each capsule containing 400 mg of Maca

Group Type EXPERIMENTAL

Placebo (Placebo trial)

Intervention Type OTHER

The Placebo capsule supplement was taken for 14 days (4 capsules per day)

Maca (Maca trial)

Intervention Type OTHER

The Maca capsule supplement was taken for 14 days, with a daily dosage of 1600 mg of Maca (equivalent to 4 capsules per day, each containing 400 mg of Maca).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo (Placebo trial)

The Placebo capsule supplement was taken for 14 days (4 capsules per day)

Intervention Type OTHER

Maca (Maca trial)

The Maca capsule supplement was taken for 14 days, with a daily dosage of 1600 mg of Maca (equivalent to 4 capsules per day, each containing 400 mg of Maca).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Badminton athletes aged between 18 and 26 years.
* Each with at least three years of playing experience and a regular exercise routine.

Exclusion Criteria

* Have smoking and drinking habits.
* People who feel unwell due to other reasons during the experiment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

26 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Science and Technology Council

FED

Sponsor Role collaborator

China Medical University, Taiwan

OTHER

Sponsor Role collaborator

China Medical University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jung-Piao Tsao

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jung-Piao Tsao

Role: STUDY_CHAIR

China Medical University, China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China Medical University

Taichung, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMUH112-REC2-148

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Betaine Effect in Speed-strength Athletes
NCT03702205 UNKNOWN PHASE2/PHASE3